A Randomized Phase II Trial Of Hypofractionated Radiotherapy For Favorable Risk Prostate Cancer-RTOG CCOP Study
Principal Investigator
Himu Lukka, MD
Status
Terminated
Date Opened To Accrual
September 29 2011
Date Closed to Accrual
February 10 2014
Date of Study Termination
May 20 2022
Disease Site
Genitourinary [GU]
Prostate
Phase
II
Developmental Therapeutics
No
Primary Objective
Data Collection Notice:
Data for this trial is being collected via the NRG/RTOG Data Center.
Patient Population
-
Target Accrual
240
Patient Study Webpage
There is no available patient study webpage available for this trial at this time.